These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12756800)

  • 1. Immunological characterisation of sub-units of the Yersinia type III secretion apparatus.
    Hill J; Underwood CD; Sundberg L; Aström H; Leary SE; Forsberg A; Titball RW
    Adv Exp Med Biol; 2003; 529():415-7. PubMed ID: 12756800
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.
    Friedlander AM; Welkos SL; Worsham PL; Andrews GP; Heath DG; Anderson GW; Pitt ML; Estep J; Davis K
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S178-81. PubMed ID: 8845449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

  • 6. A plague upon the phagocytes.
    DeLeo FR; Hinnebusch BJ
    Nat Med; 2005 Sep; 11(9):927-8. PubMed ID: 16145573
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.
    Grosfeld H; Bino T; Flashner Y; Ber R; Mamroud E; Lustig S; Velan B; Shafferman A; Cohen S
    Adv Exp Med Biol; 2003; 529():423-4. PubMed ID: 12756802
    [No Abstract]   [Full Text] [Related]  

  • 9. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A molecular basis of the plague vaccine development].
    Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP
    Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
    Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary hemochromatosis restores the virulence of plague vaccine strains.
    Quenee LE; Hermanas TM; Ciletti N; Louvel H; Miller NC; Elli D; Blaylock B; Mitchell A; Schroeder J; Krausz T; Kanabrocki J; Schneewind O
    J Infect Dis; 2012 Oct; 206(7):1050-8. PubMed ID: 22896664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for new plague vaccines.
    Feodorova VA; Corbel MJ
    Expert Rev Vaccines; 2009 Dec; 8(12):1721-38. PubMed ID: 19943765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G; Khan AA; Rao DN
    Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.